372 related articles for article (PubMed ID: 19781562)
1. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).
Fonsart J; Menet MC; Debray M; Hirt D; Noble F; Scherrmann JM; Declèves X
Toxicol Appl Pharmacol; 2009 Dec; 241(3):339-47. PubMed ID: 19781562
[TBL] [Abstract][Full Text] [Related]
2. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Fonsart J; Menet MC; Declèves X; Galons H; Crété D; Debray M; Scherrmann JM; Noble F
Toxicol Appl Pharmacol; 2008 Jul; 230(1):117-25. PubMed ID: 18358511
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.
Hirt D; Fonsart J; Menet MC; Debray M; Noble F; Declèves X; Scherrmann JM
Toxicol Sci; 2010 Mar; 114(1):38-47. PubMed ID: 20008456
[TBL] [Abstract][Full Text] [Related]
4. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
5. Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis.
Cho AK; Hiramatsu M; Distefano EW; Chang AS; Jenden DJ
Drug Metab Dispos; 1990; 18(5):686-91. PubMed ID: 1981721
[TBL] [Abstract][Full Text] [Related]
6. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
[TBL] [Abstract][Full Text] [Related]
7. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
[TBL] [Abstract][Full Text] [Related]
8. MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment.
Campbell NG; Koprich JB; Kanaan NM; Lipton JW
Neurotoxicol Teratol; 2006; 28(4):459-65. PubMed ID: 16905291
[TBL] [Abstract][Full Text] [Related]
9. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities.
De Letter EA; Bouche MP; Van Bocxlaer JF; Lambert WE; Piette MH
Forensic Sci Int; 2004 May; 141(2-3):85-90. PubMed ID: 15062945
[TBL] [Abstract][Full Text] [Related]
11. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
Segura M; Farré M; Pichini S; Peiró AM; Roset PN; Ramírez A; Ortuño J; Pacifici R; Zuccaro P; Segura J; de la Torre R
Clin Pharmacokinet; 2005; 44(6):649-60. PubMed ID: 15910012
[TBL] [Abstract][Full Text] [Related]
12. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
Chu T; Kumagai Y; DiStefano EW; Cho AK
Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874
[TBL] [Abstract][Full Text] [Related]
13. Absorption and clearance of +/-3,4-methylenedioxymethamphetamine from the plasma of neonatal rats.
Williams MT; Brown CA; Skelton MR; Vinks AA; Vorhees CV
Neurotoxicol Teratol; 2004; 26(6):849-56. PubMed ID: 15451048
[TBL] [Abstract][Full Text] [Related]
14. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
Concheiro M; Baumann MH; Scheidweiler KB; Rothman RB; Marrone GF; Huestis MA
Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
[TBL] [Abstract][Full Text] [Related]
15. Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection.
Tomita M; Nakashima MN; Wada M; Nakashima K
Biomed Chromatogr; 2007 Oct; 21(10):1016-22. PubMed ID: 17474141
[TBL] [Abstract][Full Text] [Related]
16. MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females.
Koenig J; Lazarus C; Jeltsch H; Ben Hamida S; Riegert C; Kelche C; Jones BC; Cassel JC
Pharmacol Biochem Behav; 2005 Jul; 81(3):635-44. PubMed ID: 15951008
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of MDMA/MDA in both hair and urine in drug users.
Han E; Yang W; Lee J; Park Y; Kim E; Lim M; Chung H
Forensic Sci Int; 2005 Aug; 152(1):73-7. PubMed ID: 15939177
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
Mas M; Farré M; de la Torre R; Roset PN; Ortuño J; Segura J; Camí J
J Pharmacol Exp Ther; 1999 Jul; 290(1):136-45. PubMed ID: 10381769
[TBL] [Abstract][Full Text] [Related]
19. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W
Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302
[TBL] [Abstract][Full Text] [Related]
20. Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes.
Pontes H; de Pinho PG; Fernandes E; Branco PS; Ferreira LM; Carmo H; Remião F; Carvalho F; Bastos ML
Toxicology; 2010 Apr; 270(2-3):150-7. PubMed ID: 20170704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
